Pneumocystis pneumonia | |
---|---|
Other names | Pneumocystis pneumonia; Pneumocystis jirovecii pneumonia; Pneumocystis jiroveci pneumonia; Pneumocystis carinii pneumonia [outdated term]; pneumocystosis;[1] pneumocystiasis;[1] interstitial plasma cell pneumonia;[1] plasma cell pneumonia |
Pneumocystis jirovecii cysts from bronchoalveolar lavage, stained with Toluidine blue O stain | |
Specialty | Infectious disease, Pulmonology |
Causes | Pneumocystis jirovecii[2] |
Risk factors | Weakened immune system[2] |
Differential diagnosis | Other types of pneumonia |
Medication | co-trimoxazole,[2] steroids, pentamidine, trimetrexate, dapsone, atovaquone, primaquine, pafuramidine maleate and clindamycin. |
Pneumocystis pneumonia (PCP), also known as Pneumocystis jirovecii pneumonia (PJP), is a form of pneumonia that is caused by the yeast-like fungus Pneumocystis jirovecii.[3][4]
Pneumocystis specimens are commonly found in the lungs of healthy people although it is usually not a cause for disease.[5] However, they are a source of opportunistic infection and can cause lung infections in people with a weak immune system or other predisposing health conditions. PCP is seen in people with HIV/AIDS (who account for 30-40% of PCP cases), those using medications that suppress the immune system, and people with cancer, autoimmune or inflammatory conditions, and chronic lung disease.[2]
Dorlands
was invoked but never defined (see the help page).